XML 61 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
SHARE-BASED COMPENSATION (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jan. 27, 2019
Jan. 28, 2018
Share-based Compensation [Abstract]    
Date and terms of plan modification In March 2016, shareholders approved a new equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted.  
Maximum number of shares of common stock that may be issued (in shares) 4,000,000  
Share-based compensation expense incurred $ 1,100 $ 900
Cash received from option exercises 500 700
Share-based compensation cost capitalized 0 0
Income tax benefits realized from stock option exercises $ 0 $ 0
Stock Options [Member]    
Share-based Compensation [Abstract]    
Contractual term 10 years  
Stock options, additional disclosures [Abstract]    
Share options granted (in shares) 132,000 252,000
Weighted-average grant date fair value of options granted (in dollars per share) $ 3.31 $ 2.74
Unrecognized compensation cost related to unvested option awards $ 1,600  
Period for recognition of compensation cost not yet recognized 2 years 4 months 24 days  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]    
Volatility 33.10% 31.60%
Risk free rate of return   2.20%
Dividend yield 0.00% 0.00%
Expected term 5 years 1 month 6 days 5 years
Outstanding and exercisable option awards [Roll Forward]    
Outstanding at end of period (in shares) 2,452,168  
Exercisable at end of period (in shares) 1,831,351  
Weighted Average Exercise Price [Abstract]    
Weighted average exercise price, Outstanding at end of period (in dollars per share) $ 8.84  
Weighted average exercise price, Exercisable at end of period (in dollars per share) $ 8.42  
Weighted-Average Remaining Contractual Life [Abstract]    
Weighted average remaining contractual life, Outstanding at end of period 5 years 10 months 24 days  
Weighted average remaining contractual life, Exercisable at end of period 5 years 1 month 6 days  
Aggregate Intrinsic Value [Abstract]    
Aggregate intrinsic value, Outstanding at end of period $ 4,886  
Aggregate intrinsic value, Exercisable at end of period $ 4,373  
Stock Options [Member] | Minimum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 1 year  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]    
Risk free rate of return 2.50%  
Stock Options [Member] | Maximum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 4 years  
Weighted-average inputs and risk-free rate of return ranges used to calculate the grant date fair value of options [Abstract]    
Risk free rate of return 2.90%  
Restricted Stock [Member]    
Stock options, additional disclosures [Abstract]    
Period for recognition of compensation cost not yet recognized 3 years 1 month 6 days  
Restricted Stock [Abstract]    
Restricted stock awards granted (in shares) 435,000 280,000
Weighted average grant date fair value of restricted stock awards (in dollars per share) $ 9.80 $ 8.63
Compensation cost not yet recognized related to unvested restricted stock awards $ 6,300  
Number of shares of restricted stock outstanding (in shares) 724,113  
Restricted Stock [Member] | Minimum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 1 year  
Restricted Stock [Member] | Maximum [Member]    
Share-based Compensation [Abstract]    
Award vesting period 4 years